Skip to main content
Have a personal or library account? Click to login
Hypertension Control in Bangladesh: Changes, Sociodemographic Variation, and Socioeconomic Inequality from the 2017–18 to 2022 Bangladesh Demographic and Health Surveys Cover

Hypertension Control in Bangladesh: Changes, Sociodemographic Variation, and Socioeconomic Inequality from the 2017–18 to 2022 Bangladesh Demographic and Health Surveys

Open Access
|Jul 2026

References

  1. Vaduganathan M, Mensah GA, Turco JV, Fuster V, Roth GA. The Global Burden of Cardiovascular Diseases and Risk: A Compass for Future Health. J Am Coll Cardiol, 2022.80:23612371. DOI: 10.1016/j.jacc.2022.11.005
  2. WHO. Noncommunicable diseases country profiles 2018. Geneva; 2018. https://iris.who.int/handle/10665/274512 (accessed 23 Apr 2025).
  3. WHO. Hypertension Bangladesh 2023 country profile. 2023. https://www.who.int/publications/m/item/hypertension-bgd-2023-country-profile (accessed 23 Apr 2025).
  4. WHO. National STEPS Survey for Non-communicable Diseases Risk Factors in Bangladesh 2018. 2018. https://apps.who.int/iris/handle/10665/332886 (accessed 27 Feb 2024).
  5. RESOLVE to Save Lives. Better data, better outcomes for blood pressure in Bangladesh. 2025. https://resolvetosavelives.org/about/success-stories/bangladesh-better-data-blood-pressure/ (accessed 24 Aug 2025).
  6. Abrar A, Hu X, Akhtar J, Jubayer S, Noor Nabi Sayem M, Sultana S, et al. Evaluation of the World Health Organization-HEARTS hypertension control package in Bangladesh: a quasi-experimental trial. Heart, 2024;110(17):10901098. DOI: 10.1136/heartjnl-2024-324253
  7. NCDC DGHS. National Guideline on Hypertension. 2nd ed. Dhaka: Non-Communicable Disease Control Program (NCDC); 2023. https://dghs.gov.bd/pages/publications/6922d9c281fc96cef9eb3b3b (accessed 18 Feb 2025).
  8. Frieden TR, Garg R, Banigbe B, Choudhury S, Ogbureke N, Duguma D, et al. Unlocking health equity by eliminating copayments for essential antihypertensive medications. EClinicalMedicine, 2025;81:103094. DOI: 10.1016/j.eclinm.2025.103094
  9. Pidugu A, Pickersgill S, Watkins D, Husain J, Kostova D, Farrell M, et al. National health and budget impact of implementing the WHO HEARTS hypertension control program in Bangladesh. Lancet Glob Health, 2022;10:S23. DOI: 10.1016/S2214-109X(22)00152-8
  10. Global Health Advocacy Incubator. Hypertension Control Initiative in Bangladesh. 2023. https://www.advocacyincubator.org/news/2023-05-17-hypertension-control-initiative-in-bangladesh?utm_source=chatgpt.com (accessed 27 Apr 2025).
  11. Zhou B, Danaei G, Stevens GA, Bixby H, Taddei C, Carrillo-Larco RM, et al. Long-term and recent trends in hypertension awareness, treatment, and control in 12 high-income countries: An analysis of 123 nationally representative surveys. The Lancet, 2019;394:639651. DOI: 10.1016/S0140-6736(19)31145-6
  12. Nyame S, Iwelunmor J, Boateng D, Ogedegbe G, Heeres P, Grobbee D, et al. Community-based strategies to improve health-related outcomes in people living with hypertension in low- and middle-income countries: A systematic review and meta-analysis. Glob Heart, 2024;19. DOI: 10.5334/gh.1329
  13. [dataset] The DHS Program 2017–18. Bangladesh Demographic and Health Survey (BDHS) 2017–18. 2020. https://dhsprogram.com/data/available-datasets.cfm (accessed 30 Sep 2024).
  14. [dataset] The DHS Program. Bangladesh Demographic and Health Survey (BDHS) 2022. 2022. https://dhsprogram.com/data/available-datasets.cfm (accessed 30 Sep 2024).
  15. National Institute of Population Research and Training (NIPORT) and ICF. Bangladesh Demographic and Health Survey 2017–18. Dhaka, Bangladesh, and Rockville, Maryland, USA; 2020.
  16. National Institute of Population Research and Training (NIPORT) and ICF. Bangladesh Demographic and Health Survey 2022: Key Indicators Report. Dhaka, Bangladesh, and Rockville, Maryland, USA; 2023. https://www.dhsprogram.com/pubs/pdf/PR148/PR148.pdf (accessed 30 Sep 2024).
  17. Parasuraman G, Jeemon P, Thankappan KR, Ali MK, Mahal A, McPake B, et al. Community Control of Hypertension and Diabetes (CoCo-HD) program in the Indian states of Kerala and Tamil Nadu: A study protocol for a type 3 hybrid trial. BMC Public Health, 2024;24:2275. DOI: 10.1186/s12889-024-19746-6
  18. Valdés González Y, Campbell NRC, Pons Barrera E, Calderón Martínez M, Pérez Carrera A, Morales Rigau JM, et al. Implementation of a community-based hypertension control program in Matanzas, Cuba. J Clin Hypertens, 2020;22:142149. DOI: 10.1111/jch.13814
  19. Monower MM, Al Abid SU, Abrar AK, Choudhury SR. Salt intake across the hypertension care cascade in the Bangladeshi adult population: a nationally representative cross-sectional study. BMJ Open, 2024.14. DOI: 10.1136/bmjopen-2023-081913
  20. Bista B, Dhimal M, Bhattarai S, Neupane T, Xu YY, Pandey AR, et al. Prevalence of non-communicable diseases risk factors and their determinants: Results from STEPS survey 2019, Nepal. PLoS One. 2021;16:e0253605. DOI: 10.1371/journal.pone.0253605
  21. Babagoli MA, Chen Y-H, Chakma N, Islam MdS, Naheed A, Boettiger DC. Association of socio-demographic characteristics with hypertension awareness, treatment, and control in Bangladesh. J Hum Hypertens, 2023.37:993999. DOI: 10.1038/s41371-023-00815-z
  22. O’Donnell O, van Doorslaer E, Wagstaff A, Lindelow M. Analyzing Health Equity Using Household Survey Data. The World Bank; 2007. DOI: 10.1596/978-0-8213-6933-3
  23. Mohammad R, Bansod DW. Hypertension in India: A gender-based study of prevalence and associated risk factors. BMC Public Health, 2024;24:2681.
  24. Ministry of Health (MoH) RG of B. 5TH NATIONAL HEALTH SURVEY of BHUTAN: Integrated Stepwise Household Survey 2023. 2023. Website: https://www.health.gov.bt (accessed 24 Apr 2025).
  25. Koya SF, Pilakkadavath Z, Chandran P, Wilson T, Kuriakose S, Akbar SK, et al. Hypertension control rate in India: systematic review and meta-analysis of population-level non-interventional studies, 2001–2022. The Lancet Regional Health – Southeast Asia, 2023;9. DOI: 10.1016/j.lansea.2022.100113
  26. Dhungana RR, Pandey AR, Shrestha N. Trends in the prevalence, awareness, treatment, and control of hypertension in Nepal between 2000 and 2025: A systematic review and meta-analysis. Int J Hypertens. 2021;2021:6610649. DOI: 10.1155/2021/6610649
  27. Kim K, Ji E, Choi J, Kim S, Ahn S, Kim C-H. Ten-year trends of hypertension treatment and control rate in Korea. Sci Rep, 2021.11(1):6966. DOI: 10.1038/s41598-021-86199-x
  28. Kim HC, Lee H, Lee HH, Lee G, Kim E, Song M, et al. Korea hypertension fact sheet 2022: Analysis of nationwide population-based data with a special focus on hypertension in the elderly. Clin Hypertens, 2023;29(1):22. DOI: 10.1186/s40885-023-00243-8
  29. Chow CK, Teo KK, Rangarajan S, Islam S, Gupta R, Avezum A, et al. Prevalence, awareness, treatment, and control of hypertension in rural and urban communities in high-, middle-, and low-income countries. JAMA, 2013;310:959968. DOI: 10.1001/jama.2013.184182
  30. World Heart Federation. Hypertension. https://world-heart-federation.org/what-we-do/hypertension (accessed 27 Apr 2025).
  31. Sepanlou S, Najafi F, Poustchi H, Parsaeian M, Ahmadi A, Somi M, et al. Prevalence, awareness, treatment, and control of hypertension based on ACC/AHA versus JNC7 guidelines in the PERSIAN cohort study. Sci Rep, 2022;12(1):4057. DOI: 10.1038/s41598-022-07896-9
  32. Doumat G, Daher D, Itani M, Abdouni L, El Asmar K, Assaf G. The effect of polypharmacy on healthcare services utilization in older adults with comorbidities: a retrospective cohort study. BMC Primary Care, 2023.24(1):120. DOI: 10.1186/s12875-023-02070-0
  33. Pachauri S. Sexual and reproductive health services: Priorities for South and East Asia. Indian J Community Med. 2011;36:8384. DOI: 10.4103/0970-0218.84116
  34. Darvishpour A, Mansour-Ghanaei R, Mansouri F. The relationship between health literacy, self-efficacy, and self-care behaviors in older adults with hypertension in the north of Iran. Health Lit Res Pract, 2022.6:e262e269. DOI: 10.3928/24748307-20221013-01
  35. Attaei MW, Khatib R, McKee M, Lear S, Dagenais G, Igumbor EU, et al. Availability and affordability of blood pressure-lowering medicines and the effect on blood pressure control in high-income, middle-income, and low-income countries: An analysis of the PURE study data. Lancet Public Health, 2017;2:e411e419. DOI: 10.1016/S2468-2667(17)30141-X
  36. Asia Arsenic Network. Strengthening Community Capacity for Non-Communicable Disease Prevention in Khulna Division Final Report. 2019. https://www.aan-ncd.org/ (accessed 9 Sep 2025).
  37. Ipsita Sutradhar A, Hasan M, Mokbul Hossain M, Showkat Ali Khan M, YoshimuraMd Moyazzam Hossain Y, Reza Choudhury S, et al. Strengthening Health Systems through Organizing Communities (SHASTO) Baseline Survey Report; 2018.
  38. WHO. Implementation roadmap 2023–2030 for the Global action plan for the prevention and control of NCDs 2013–2030. https://www.who.int/teams/noncommunicable-diseases/governance/roadmap (accessed 29 Apr 2025).
DOI: https://doi.org/10.5334/gh.1575 | Journal eISSN: 2211-8179
Language: English
Page range: 58 - 58
Submitted on: Feb 5, 2026
Accepted on: Jul 13, 2026
Published on: Jul 27, 2026
Published by: Ubiquity Press
In partnership with: Paradigm Publishing Services

© 2026 Md Mostafa Monower, Shehab Uddin Al Abid, Shamim Jubayer, Mahfuzur Rahman Bhuiyan, Mohammad Abdullah Al Mamun, Sohel Reza Choudhury, published by Ubiquity Press
This work is licensed under the Creative Commons Attribution 4.0 License.